Status:
UNKNOWN
Efficacy of Extracorporeal Shock Wave Therapy in Carpal Tunnel Syndrome
Lead Sponsor:
University of Beykent
Conditions:
Carpal Tunnel Syndrome
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
The aim of the study is to examine the effects of ESWT applications at different pulse rates on pain, function, grip strength and median nerve conduction velocity in patients with Carpal Tunnel Syndro...
Detailed Description
The aim of the study is to examine the effects of ESWT applications at different pulse rates on pain, function, grip strength and median nerve conduction velocity in patients with Carpal Tunnel Syndro...
Eligibility Criteria
Inclusion
- Being between the ages of 18-65,
- Clinical symptoms persisting for at least 3 months
- Pain, tingling and paresthesia in the first 3 fingers together with the Phalen and Tinel test makes the patient positive,
- Patients who are positive are evaluated by a specialist in electrodiagnostic testing and the clinical stage of CTS is determined.
- Mild to moderate CTS is diagnosed if the sensory nerve action potential (SNAP) is \>6 μV and the combined muscle action potential (CMAP) is \>2.1 mV.
- Being diagnosed with mild and moderate CTS
Exclusion
- The patient who received CTS operation or corticosteroid treatment,
- Presence of systemic diseases that will affect our treatment such as diabetes, rheumatoid arthritis, gout,
- It has been determined as atrophy in the thenar region of the hand (Xu,2020).
Key Trial Info
Start Date :
May 30 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 20 2022
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT05314777
Start Date
May 30 2022
End Date
December 20 2022
Last Update
June 2 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Gaziosmanpasa Training and Research Hospital
Istanbul, Turkey (Türkiye), 34488